Fogarasi, A. (2016). EFFECTS: An expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex. London; Berlin; Heidelberg: BioMed Central; Springer.

EFFECTS : An expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex / Andras Fogarasi, Liesbeth De Waele, Gabriella Bartalini, Sergiusz Jozwiak, Nicola Laforgia, Helene Verhelst, Borivoj Petrak, Jean-Michel Pedespan, Olaf Witt, Ramon Castellana, Stefania Crippa, Gabriella Gislimberti and Zsuzsanna Gyorsok . — London; Berlin; Heidelberg : BioMed Central; Springer, 2016. — 1 Online-Ressource (9 Seiten)

Fogarasi, Andras. EFFECTS: An Expanded Access Program of Everolimus for Patients With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex.London; Berlin; Heidelberg: BioMed Central; Springer, 2016.